PRIMA-1(MET) induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells

There is an intensive need for the development of novel drugs for the treatment of epithelial ovarian cancer (EOC), the most lethal gynecologic malignancy due to the high recurrence rate. TP53 mutation is a common event in EOC, particularly in high-grade serous ovarian cancer, where it occurs in mor...

Descripción completa

Detalles Bibliográficos
Autores principales: YOSHIKAWA, NOBUHISA, KAJIYAMA, HIROAKI, NAKAMURA, KAE, UTSUMI, FUMI, NIIMI, KAORU, MITSUI, HIROKO, SEKIYA, RYUICHIRO, SUZUKI, SHIRO, SHIBATA, KIYOSUMI, CALLEN, DAVID, KIKKAWA, FUMITAKA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811399/
https://www.ncbi.nlm.nih.gov/pubmed/26986846
http://dx.doi.org/10.3892/or.2016.4653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811399/
https://www.ncbi.nlm.nih.gov/pubmed/26986846
http://dx.doi.org/10.3892/or.2016.4653

Ejemplares similares